U.S. Federal Reserve Rate Hike: Fed Officials Deliver Mixed Messages, But Nod Toward December Hike
Many Fed officials, including William Dudley, president of the Federal Reserve Bank of New York, suggested the likelihood of a liftoff from near-zero interest rates by year's end.
Elizabeth Warren: Congressional Favor Let Wall Street Keep $10 Trillion In Risky Swaps On Its Books
Senator Elizabeth Warren said a financial reform repeal last year let banks keep $10 trillion in risky financial assets in federally insured accounts.
JPMorgan Hack: Charges Filed Over Record Hacking Scheme At Top US Bank
The top American bank was among several institutions targeted by a hacking and stock-manipulation scheme, according to U.S. Attorney Preet Bharara.
Valeant Investor Call Outlines Revenue Hit After Specialty Pharma Debacle
Wall Street has hammered the Canadian company for its recently terminated ties to a specialty drug maker with controversial pricing practices.
Goldman Predicts Corporate Spending In 2016 To Lean Toward Shareholders
Corporate spending on share buybacks and dividends will rise next year faster than research investments, Goldman's top equity analyst said in a note Monday.
With Crude Prices At Historic Lows, Saudi Arabia Pledges To Keep Oil Coming
Low crude prices will likely continue, as Saudi officials said they have no plans to reduce oil drilling.
French Central Bank Chief Nods Toward Monetary Easing
Ahead of a crucial European Central Bank meeting in December, Bank of France chief François Villeroy de Galhau praised monetary stimulus.
Israel Shared ISIS Communications On Russian Plane Crash In Sinai: CNN
The Islamic State group was implicated by Israeli intelligence in the Sinai plane crash that killed 224 Russians, sources told CNN.
James Bond Tops Box Office With 'Spectre'
The 24th film in the James Bond franchise proved a box-office hit, with studios estimating a $73 million haul in its opening weekend.
Trump Draws Huge Ratings On 'Saturday Night Live' As Protestors Bemoan His Appearance
The billionaire GOP presidential contender brought season-high viewership to "Saturday Night Live," despite protests from Latino groups.
European Business Travel Set To Rise, Bolstering Economic Hopes
A key indicator of economic health, business travel is forecast to rise by more than 6 percent in Europe next year, according to a new study.
Marco Rubio Pulls Senators Off Bush Bandwagon
Although few Republican U.S. senators have made endorsements in the GOP presidential race, momentum has shifted to Marco Rubio from Jeb Bush.
October Jobs Report: Prime-Age Employment Ratio Languishes, But Change Could Be Around The Corner
The low share of prime-age adults in the U.S. workforce hasn't budged since January. That could change soon.
Exxon Mobil Corporation (XOM): How Investigators Hope To Prove The Oil Giant Wronged Investors Over Climate Change
How New York Attorney General Eric Schneiderman is hoping to use a state securities law to prove the oil giant misled investors on climate change.
Months After Bitcoin Consumer Protection Laws Enacted, Digital Currency Businesses Have Fled New York Market
Three months after the state mandated that digital currency firms guard against money laundering and fraud, at least 20 have left the state.
Bitcoin Rally: Digital Currency's Surge Driven By China, Speculators, The Blockchain (And Ponzi Schemers?)
Five factors are at play in Bitcoin's double-digit gains against the dollar, but enthusiasts are troubled by one of them.
Crisis-Stricken Valeant Pharmaceuticals Intl Inc (VRX) Gets Redoubled Support From Hedge Funder Bill Ackman
The prominent hedge fund manager launched a two-hour defense of Valeant Pharmaceuticals International Inc. as the company's shares continue to tank.
Valeant Pharmaceuticals International Inc (VRX) Cuts Ties With Philidor After Specialty Pharmacy Practices Questioned
The Canadian drug manufacturer is terminating its relationship with Philidor RX, a specialty pharmacy that has come under scrutiny.
Valeant Pharmaceuticals International Inc (VRX) Drops On Report CVS Cut Ties With Specialty Pharmacy
The Canadian pharmaceutical company saw its shares drop after reports that CVS had cut ties with Philidor RX, Valeant's embattled specialty pharmacy.
House Quietly Passes Bill To Thwart Protections For Retirement Savers
Congressional Republicans are looking to thwart efforts by the White House to keep retirement advisers from offering what some call conflicted advice.
Fed Rate Hike: Three Things We Learned From The October Fed Meeting
A Federal Reserve committee chose Wednesday to once again keep benchmark interest rates at historic lows -- but may be considering a December rate hike.
Fed Rate Hike: Yellen Maintains Near-Zero Interest Rate
The stage was set by a disappointing September jobs report and the manufacturing sector falling short of expectations.
Activist Investor Carl Icahn Urges AIG To Break Up
Activist investor and billionaire Carl Icahn told AIG it was too large and unwieldy in an open letter calling for the insurance company to restructure.
International Business Machines Corp (IBM) Discloses SEC Investigation Into Accounting Practices
International Business Machines disclosed Tuesday the Securities and Exchange Commission is looking into its accounting practices.
Valeant Woes Multiply With Federal Antitrust Probe Into Contact Lens Business
Even as the pharmaceutical giant bats away concerns over its complex pharmacy model, federal investigators have launched a new antitrust probe.
Valeant Pharmaceuticals Seeks To Calm Investors, But New Questions Emerge
The Canadian drugmaker answered concerns from investors over its embattled specialty pharmacy model, but more questions are emerging.
Valeant Pharmaceuticals Intl Inc (VRX): Amid Fraud Allegations And Sinking Stock Price, Four Big Questions Loom
After a week of bombshell allegations and investor panic, the pharmaceutical giant's executives must explain away loud accusations of fraud.
With China Central Bank Interest Rate Cut, Investors Cheer, Economists Worry
The country's central bank cut interest rates Friday for the sixth time since November in an attempt to boost demand and shore up flagging industries.
Valeant (VRX) Strengthens Defense After Two Days Of Market Punishment
The Canadian pharmaceutical company denied fraud allegations and scheduled a special call with analysts for Monday as investors continued to pull away.
Debt Ceiling Fears: Treasury Department Postpones Auction Over Borrowing Limit Fears
The U.S. Treasury Department put a sale of 2-year notes on hold over fears that Congress will fail to raise the debt ceiling in time.
